126 related articles for article (PubMed ID: 12753918)
1. Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site.
Leibovitch MP; Kannengiesser C; Leibovitch SA
FEBS Lett; 2003 May; 543(1-3):125-8. PubMed ID: 12753918
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
3. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
4. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
Hattori N; Davies TC; Anson-Cartwright L; Cross JC
Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
[TBL] [Abstract][Full Text] [Related]
5. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
[TBL] [Abstract][Full Text] [Related]
6. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
[TBL] [Abstract][Full Text] [Related]
7. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
Lee MH; Reynisdóttir I; Massagué J
Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent changes of p57(Kip2) and p21(Cip1/Waf1) expression in skeletal muscle and lung of mice.
Park CW; Chung JH
Biochim Biophys Acta; 2001 Aug; 1520(2):163-8. PubMed ID: 11513958
[TBL] [Abstract][Full Text] [Related]
9. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of MyoD by direct binding to p57(Kip2).
Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
[TBL] [Abstract][Full Text] [Related]
12. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.
Watanabe H; Pan ZQ; Schreiber-Agus N; DePinho RA; Hurwitz J; Xiong Y
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1392-7. PubMed ID: 9465025
[TBL] [Abstract][Full Text] [Related]
13. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
15. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.
Takahashi K; Kobayashi T; Kanayama N
Mol Hum Reprod; 2000 Nov; 6(11):1019-25. PubMed ID: 11044465
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
[TBL] [Abstract][Full Text] [Related]
17. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
Yan Y; Frisén J; Lee MH; Massagué J; Barbacid M
Genes Dev; 1997 Apr; 11(8):973-83. PubMed ID: 9136926
[TBL] [Abstract][Full Text] [Related]
18. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
[TBL] [Abstract][Full Text] [Related]
19. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development.
Zhang P; Wong C; DePinho RA; Harper JW; Elledge SJ
Genes Dev; 1998 Oct; 12(20):3162-7. PubMed ID: 9784491
[TBL] [Abstract][Full Text] [Related]
20. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]